NCT07322653

The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

Prospective, Open-Label, Multicenter Study to Characterise the Effects of Co-administration of MediDrink Platinum+ Formula Containing Novel Protein Blend SPR-01 and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Nuritas Ltd · Industry
• Sex: All
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia

Detailed description

The primary aim of this multicentre randomised active control group study , is to characterise the effect of MediDrink Platinum+ containing a novel protein blend SPR-01, alone and in combination with PeptiStrong on general fitness measured via the Barthel index in malnourished sarcopenic, adults, aged 60 and above. The trial will incorporate a "Y" design whereby all 75 participants begin on the base formula (MediDrink Platinum) for 2 weeks before being randomised into the SPR-01 alone (n=37, dose calculated per individual but at least 1200 kcal/day) or SP1-01 and PeptStrong (n=38, dose calculated per individual but at least 1200 kcal per day and 2.4g/day, respectively) supplementation arms for 10 weeks. Other clinical endpoints measured as secondary endpoints will include hand grip strength, physical functioning via time up\&go test and changes in fat-free body mass.

Conditions

• Sarcopenia in Elderly
• Malnourished
• Protein Supplementation
• Muscle Mass
• Physical Function
• Strength

Interventions

Type	Name	Description
OTHER	MediDrink Platinum+	MediDrink Platinum+ containing novel protein blend SPR-01
OTHER	MediDrink Platinum+ and PeptiStrong	MediDrink Platinum+ containing novel protein blend SPR-01 and PeptiStrong, fava bean protein hydrolysate

Timeline

• Start date: 2025-09-10
• Primary completion: 2026-10-01
• Completion: 2027-01-02
• First posted: 2026-01-07
• Last updated: 2026-01-07

Locations

2 sites across 1 country: Hungary